Management of Diabetes-associated Cognitive Impairment: Emerging Therapeutic Approaches
Year: 2026
Type: article
Abstract: Diabetes mellitus represents a chronic metabolic condition defined by sustained hyperglycemia, which stems from defective insulin secretion, compromised insulin action, or a combination of both. Extending beyond its established vascular and metabolic sequelae, an accumulating body of evidence indicates that diabetes plays a substantial role in the pathogenesis of cognitive decline. Persons afflicted with diabetes face an elevated susceptibility to memory deterioration, diminished learning capacity, disrupted executive function, and neurodegenerative pathologies, including Alzheimer's disease. The etiology of these neurological consequences is multifactorial, encompassing insulin resistance, chronic hyperglycemia, oxidative stress, neuroinflammation, mitochondrial dysfunction, vascular irregularities, and compromised neuronal signaling. Existing therapeutic approaches to diabetes-associated cognitive impairment are chiefly predicated on enhancing cognitive performance and decelerating the trajectory of the disease. While conventional pharmacological interventions, specifically donepezil and memantine, have yielded only marginal improvements, emerging antidiabetic therapies, particularly GLP-1 receptor agonists, have exhibited considerable promise in terms of neuroprotection. Furthermore, a range of phytochemicals, notably curcumin, resveratrol, and berberine, have garnered significant interest due to their robust antioxidant and anti-inflammatory properties. Among these naturally derived substances, usnic acid—a dibenzofuran derivative sourced from lichens—has recently surfaced as a compelling candidate for neuroprotective therapy. Consequently, a more rigorous exploration of usnic acid within experimental frameworks modeling diabetes-induced cognitive impairment holds the potential to yield critical insights for formulating efficacious, cost-effective, and secure therapeutic strategies aimed at mitigating or managing cognitive deterioration linked to diabetes.
Authors: Syeda Sumaiya, Nomula Pavani, Dr. M. Sreekanth
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235369298
